The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Passive antibody therapy for infectious diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292102 · Cited by 744
Ueber das Zustandekommen der Diphtherie-Immunität und der Tetanus-Immunität bei Thieren
(1890) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1207589 · Cited by 643
Immunotherapy: past, present and future
Waldmann, T. A. (2003) · Nature Medicine · doi:10.1038/nm0303-269 · Cited by 628
Frickhofen, N., Abkowitz, J. L., Safford, M., Berry, J. M., Antunez-de-Mayolo, J., Astrow, A., Cohen, R., Halperin, I., King, L., Mintzer, D., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-926 · Cited by 471
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
Pethe, K., Alonso, S., Biet, F., Delogu, G., Brennan, M. J., Locht, C., & Menozzi, F. D. (2001) · Nature · doi:10.1038/35084083 · Cited by 468
Robbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
Green, L. L., Hardy, M. C., Maynard-Currie, C. E., Tsuda, H., Louie, D. M., Mendez, M. J., Abderrahim, H., Noguchi, M., Smith, D. H., Zeng, Y., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-13 · Cited by 355
Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation
Wentworth, P., McDunn, J. E., Wentworth, A. D., Takeuchi, C., Nieva, J., Jones, T., Bautista, C., Ruedi, J. M., Gutierrez, A., Janda, K. D., et al. (2002) · Science · doi:10.1126/science.1077642 · Cited by 349
Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases
Casadevall, A., & Scharff, M. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.150 · Cited by 318
Self-citationA mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival
Teitelbaum, R., Glatman-Freedman, A., Chen, B., Robbins, J. B., Unanue, E., Casadevall, A., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15688 · Cited by 275
Self-citationAngus, D. C. (2000) · JAMA · doi:10.1001/jama.283.13.1723 · Cited by 266
Serum therapy revisited: animal models of infection and development of passive antibody therapy
Casadevall, A., & Scharff, M. D. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1695 · Cited by 251
Self-citationMatthews, R. C., Rigg, G., Hodgetts, S., Carter, T., Chapman, C., Gregory, C., Illidge, C., & Burnie, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2208-2216.2003 · Cited by 231
Rodrigues, M. L., Travassos, L. R., Miranda, K. R., Franzen, A. J., Rozental, S., de Souza, W., Alviano, C. S., & Barreto-Bergter, E. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.7049-7060.2000 · Cited by 218
Glatman-Freedman, A., & Casadevall, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.514 · Cited by 215
Self-citationAntibodies to a cell surface histone-like protein protect against Histoplasma capsulatum
Nosanchuk, J. D., Steenbergen, J. N., Shi, L., Deepe, G. S., & Casadevall, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19361 · Cited by 178
Self-citationTHE RESULTS OF THE SERUM TREATMENT IN THIRTEEN HUNDRED CASES OF EPIDEMIC MENINGITIS
Flexner, S. (1913) · Journal of Experimental Medicine · doi:10.1084/jem.17.5.553 · Cited by 176
Antibody-mediated regulation of cellular immunity and the inflammatory response
Casadevall, A., & Pirofski, L.-A. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00228-x · Cited by 168
Self-citationMore Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG
Taborda, C. P., Rivera, J., Zaragoza, O., & Casadevall, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3621 · Cited by 166
Self-citationMoragues, M. D., Ibarra, M. J. O., Elguezábal, N., Sevilla, M. J., Conti, S., Polonelli, L., & Pontón, J. (2003) · Infection and Immunity · doi:10.1128/iai.71.9.5273-5279.2003 · Cited by 157
Derkx, B., Wittes, J. T., McCloskey, R. V., & the European Pediatric Meningococcal Septic Shock Trial Study Group (1999) · Clinical Infectious Diseases · doi:10.1086/515184 · Cited by 156
Han, Y., Ulrich, M. A., & Cutler, J. E. (1999) · The Journal of Infectious Diseases · doi:10.1086/314779 · Cited by 145
Devi, S. J. (1996) · Vaccine · doi:10.1016/0264-410x(95)00256-z · Cited by 145
Yuan, R., Casadevall, A., Spira, G., & Scharff, M. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1810 · Cited by 141
Self-citationMukherjee, J., Zuckier, L. S., Scharff, M. D., & Casadevall, A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.580 · Cited by 136
Self-citationCutting Edge: Paradigm Revisited: Antibody Provides Resistance to Listeria Infection
Edelson, B. T., Cossart, P., & Unanue, E. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4087 · Cited by 133
Greenberg, P. D., & Cello, J. P. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199612010-00008 · Cited by 119
The Use of Vaccinia Hyperimmune Gammaglobulin in the Prophylaxis of Smallpox
Kempe, C. H., Bowles, C., Meiklejohn, G., Berge, T. O., Saint-Vincent, L., Babu, B. V. S., Govindarajan, S., Ratnakannan, N. R., Downie, A. W., & Murthy, V. R. (2015) · KARGER eBooks · doi:10.1159/000389848 · Cited by 111
Polonelli, L., Bernardis, F. D., Conti, S., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.3175 · Cited by 110
Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection
Dadachova, E., Nakouzi, A. S., Bryan, R. A., & Casadevall, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1731272100 · Cited by 107
Self-citationCasadevall, A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4225-4228.2003 · Cited by 105
Self-citationTaborda, C. P., & Casadevall, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2100 · Cited by 101
Self-citationSerologic Therapy of Tetanus in the United States, 1965-1971
Blake, P. A. (1976) · JAMA · doi:10.1001/jama.1976.03260270028022 · Cited by 86
A Human IgM Monoclonal Antibody Prolongs Survival of Mice with Lethal Cryptococcosis
Fleuridor, R., Zhong, Z., & Pirofski, L. (1998) · The Journal of Infectious Diseases · doi:10.1086/515688 · Cited by 83
Self-citationPolysaccharides, mimotopes and vaccines for fungal and encapsulated pathogens
Pirofski, L. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02134-5 · Cited by 82
Self-citationBuchwald, U. K., & Pirofski, L. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455189 · Cited by 73
Self-citationTill, M. A., Zolla‐Pazner, S., Górny, M. K., Patton, J. S., Uhr, J. W., & Vitetta, E. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.6.1987 · Cited by 65
Feasibility of Radioimmunotherapy of Experimental Pneumococcal Infection
Dadachova, E., Burns, T., Bryan, R. A., Apostolidis, C., Brechbiel, M. W., Nosanchuk, J. D., Casadevall, A., & Pirofski, L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1624-1629.2004 · Cited by 60
Self-citationMaitta, R. W., Datta, K., Chang, Q., Luo, R. X., Witover, B., Subramaniam, K. S., & Pirofski, L. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4810-4818.2004 · Cited by 59
Self-citation(2004) · PubMed · Cited by 56
Chronic ECHO type 5 virus meningoencephalitis in X‐linked hypogammaglobulinemia
Bodensteiner, J. B., Morris, H. H., Howell, J. T., et al. (1979) · Neurology · doi:10.1212/wnl.29.6.815 · Cited by 50
Taylor, R. P., Martin, E. N., Reinagel, M. L., Nardin, A., Craig, M., Choice, Q., Schlimgen, R., Greenbaum, S., Incardona, N. L., & Ochs, H. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.8.4035 · Cited by 48
Chang, Q., Zhong, Z., Lees, A., Pekna, M., & Pirofski, L. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4977-4986.2002 · Cited by 46
Self-citationTargeting of Pseudomonas aeruginosa in the Bloodstream with Bispecific Monoclonal Antibodies
Lindorfer, M. A., Nardin, A., Foley, P. L., Solga, M. D., Bankovich, A. J., Martin, E. N., Henderson, A. L., Price, C. W., Gyimesi, E., Wozencraft, C. P., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2240 · Cited by 43
Serum Therapy for Cryptococcal Meningitis
Gordon, M. A., & Casadevall, A. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1477 · Cited by 42
Self-citationCombinatorial immunoglobulin libraries in phage λ
Kang, A. S., Burton, D. R., & Lerner, R. A. (1991) · Methods · doi:10.1016/s1046-2023(05)80211-7 · Cited by 41
Vaccines for the prevention of diseases caused by potential bioweapons
Hassani, M., Patel, M. C., & Pirofski, L. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.09.010 · Cited by 31
Self-citationDadachova, E., Bryan, R. A., Frenkel, A., Zhang, T., Apostolidis, C., Nosanchuk, J. S., Nosanchuk, J. D., & Casadevall, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1004-1006.2004 · Cited by 31
Self-citationPrevention of respiratory syncytial virus infection in infants
Handforth, J., Sharland, M., & Friedland, J. S. (2004) · BMJ · doi:10.1136/bmj.328.7447.1026 · Cited by 28
Selective cytotoxicity of ricin A chain immunotoxins towards murine cytomegalovirus-infected cells
Barnett, B. B., Smee, D. F., Malek, S. M., & Sidwell, R. W. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.470 · Cited by 15
Cited by
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L.-A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 903
Self-citationBeyond binding: antibody effector functions in infectious diseases
Lu, L. L., Suscovich, T. J., Fortune, S. M., & Alter, G. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.106 · Cited by 825
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., van Buskirk, C., Grossman, B. J., Joyner, M., Henderson, J. P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138745 · Cited by 799
Self-citationFrom Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
van Griensven, J., Edwards, T., de Lamballerie, X., Semple, M. G., Gallian, P., Baize, S., Horby, P. W., Raoul, H., Magassouba, N., Antierens, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1511812 · Cited by 536
Metadata
- Authors
- Casadevall, A., Dadachova, E., & Pirofski, L.-A.
- Venue
- Nature Reviews Microbiology
- Published
- 2004-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 695-703
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W1992274022
- Cited by
- 531
- References
- 52
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.